Very early researchEnded earlyNCT01317017What this trial is testingCell Responses to IFN-gammaWho this might be right forPlaque Psoriasis Rockefeller University 2
Not applicableStudy completedNCT04433442What this trial is testingStudy to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic ArthritisWho this might be right forPsoriasisPsoriatic Arthritis AbbVie 2,324
Post-approval studies (Phase 4)Study completedNCT00493324What this trial is testingStudy to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Astellas Pharma Inc 43
Testing effectiveness (Phase 2)Ended earlyNCT02201524What this trial is testingStudy to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisWho this might be right forPlaque Psoriasis Pfizer 59
Early research (Phase 1)UnknownNCT02918123What this trial is testingSafety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Kang Stem Biotech Co., Ltd. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT06846541What this trial is testingLong-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisWho this might be right forPlaque PsoriasisPsoriasis (PsO)Psoriasis+2 more Alumis Inc 1,680
Testing effectiveness (Phase 2)Study completedNCT01901705What this trial is testingTopical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type PsoriasisWho this might be right forPsoriasis China Medical University Hospital 24
Testing effectiveness (Phase 2)Temporarily pausedNCT01228656What this trial is testingEffectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone FuroateWho this might be right forPlaque Psoriasis Azidus Brasil 40
Testing effectiveness (Phase 2)Study completedNCT00770965What this trial is testingPhase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type PsoriasisWho this might be right forChronic Plaque Psoriasis Novartis Pharmaceuticals 80
Post-approval studies (Phase 4)Study completedNCT02340169What this trial is testingAdrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque PsoriasisWho this might be right forPlaque Psoriasis Sun Pharmaceutical Industries, Inc. 129
Not applicableStudy completedNCT00678470What this trial is testingOpen Label Study of Alefacept Injections to Patients With Moderate to Severe PsoriasisWho this might be right forModerate to Severe Psoriasis University of California, San Francisco 18
Not applicableWithdrawnNCT01758705What this trial is testingPost Marketing Observational Study on Venezuelan Patients With PsoriasisWho this might be right forModerate to Severe Chronic Plaque Psoriasis AbbVie (prior sponsor, Abbott)
Large-scale testing (Phase 3)Study completedNCT02074982What this trial is testingEfficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisWho this might be right forChronic Plaque Type Psoriasis Novartis Pharmaceuticals 676
Post-approval studies (Phase 4)Looking for participantsNCT04537689What this trial is testingOutcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque PsoriasisWho this might be right forPlaque Psoriasis Singapore General Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT03339999What this trial is testingAGN-242428 in the Treatment of Plaque PsoriasisWho this might be right forPlaque Psoriasis Vitae Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00408187What this trial is testingRandomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsWho this might be right forPsoriasis Aurinia Pharmaceuticals Inc. 642
Post-approval studies (Phase 4)Study completedNCT04571567What this trial is testingEvaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Saakshi Khattri 20
Large-scale testing (Phase 3)Study completedNCT03390101What this trial is testingAn International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Biocad 213
Testing effectiveness (Phase 2)Study completedNCT02905006What this trial is testingStudy to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma S.P.R.L. 250
Post-approval studies (Phase 4)Study completedNCT00581100What this trial is testingEffects of Etanercept on Nail Psoriasis and Plaque PsoriasisWho this might be right forNail PsoriasisPlaque Psoriasis Wyeth is now a wholly owned subsidiary of Pfizer 136